Improved Gastrointestinal Involvement in Systemic Sclerosis after Immunoglobulin Treatment / 대한내과학회지
Korean Journal of Medicine
; : 213-218, 2017.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-193477
Biblioteca responsável:
WPRO
ABSTRACT
Systemic sclerosis is an intractable clinical subset characterized by diffuse fibrosis, vasculopathy, and immune abnormalities. Diffuse cutaneous systemic sclerosis has a variety of symptoms depending on the internal organs involved, such as the lungs, heart, kidneys, and gastrointestinal system. Gastrointestinal involvement is frequent and one of the major cause of morbidity and mortality. There is no sustained, effective therapy for treating the active gastrointestinal involvement of systemic sclerosis. Although immunoglobulin is commonly used in the treatment of other autoimmune diseases, its effects in the treatment of the gastrointestinal involvement in systemic sclerosis are unclear. Here, we report a patient with a severe cough caused by uncontrolled gastrointestinal involvement in diffuse cutaneous systemic sclerosis treated with immunoglobulin.
Texto completo:
Disponível
Contexto em Saúde:
ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis
Problema de saúde:
Doenças Imunológicas
/
Doenças Musculoesqueléticas e Reumáticas
/
Outras Doenças Respiratórias
/
Doenças da Pele
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Escleroderma Sistêmico
/
Doenças Autoimunes
/
Fibrose
/
Imunoglobulinas
/
Mortalidade
/
Tosse
/
Esclerodermia Difusa
/
Coração
/
Rim
/
Pulmão
Tipo de estudo:
Estudo prognóstico
Limite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Ano de publicação:
2017
Tipo de documento:
Artigo